Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Evaluating Population Interest in Vitiligo Through an Analysis of Google Trends and Social Media

By No Comments
INTRODUCTIONVitiligo is an autoimmune pigmentary condition with a complex, multifactorial pathogenesis resulting in depigmentation of skin. It affects between 0.4-2% of the population worldwide.1 In recent years, vitiligo has seen…
Read More
Dec 10
Love0

Assessing a Paradigm Shift: Perceptions of the USMLE Step 1 Scoring Change to Pass/Fail

By No Comments
INTRODUCTIONThe United States Medical Licensing Exam (USMLE) Step 1 scores are heavily factored for dermatology interview selection.1 Recently, the Step 1 scoring system changed from a three-digit score to Pass/Fail…
Read More
Dec 10
Love0

Treating Inflammation in Rosacea: Current Options and Unmet Needs

By No Comments
INTRODUCTIONRosacea has been described in the medical literature for centuries.1 Twentieth-century medical publications referred to multiple phases of rosacea, typically asserting its pathophysiology as “unknown.”2 In 2002, the National Rosacea…
Read More
Dec 10
Love0

COVID-19 Supply Chain Considerations for Prescription Drugs in Dermatology

By No Comments
INTRODUCTIONOn January 30th the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC), followed by an official announcement on February 11th that the outbreak was caused…
Read More
Dec 10
Love0

Biologics and Small Molecules in the Treatment of COVID-19

By No Comments
INTRODUCTIONThe novel corona virus disease (COVID-19) is caused by a virus belonging to the betacorona virus family.1 The highly infectious nature of the disease, ability to spread through asymptomatic carriers,…
Read More
Dec 10
Love0

Treatment of Moderate to Severe Acne and Scars With a 650-Microsecond 1064-nm Laser and Isotretinoin

By No Comments
INTRODUCTIONTradition holds that laser procedures to treat acne vulgaris should be postponed at least 6 to 8 months after the end of systemic therapy with isotretinoin. This is based on…
Read More
Dec 10
Love0

Development of a Photonumeric Lip Health Scale

By No Comments
INTRODUCTIONThe lips are central to many critical human functions, for example, by facilitating breathing, speech, eating, and intimacy.1-4 The lips are also a common characteristic defining facial aesthetics. Full lips…
Read More
Dec 10
Love0

Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis

By No Comments
INTRODUCTIONAtopic dermatitis (AD) is a chronic inflammatory skin disease characterized by eczematous lesions and pruritus that occurs in approximately 15%-30% of children and 2%-10% of adults worldwide.1,2 AD causes psychological,…
Read More
Dec 10
Love0

United States Stock Market Response to FDA Approval of New Dermatologic Drugs

By No Comments
INTRODUCTIONThe approval of new drugs by the United States (U.S.) Food and Drug Administration (FDA) is a lengthy process, typically taking between 10-15 years from pre-clinical testing to approval, with…
Read More
Dec 10
Love0

The New Psoriasis Paradigm: Striving for Complete Clearance

By No Comments
INTRODUCTIONPsoriasis has a profound impact on the quality of life of its affected patients.1 Disturbing their emotional, social, physical, and financial well being, patients with psoriasis have reported a wide…
Read More
Dec 10
Love0

Consensus on Neonatal Through Preadolescent Acne

By No Comments
INTRODUCTIONAcne vulgaris, the most common dermatological disorder, can occur in the first weeks, months, or years of life.1-3 Pediatric acne can be categorized by age and pubertal status. Acne flares…
Read More
Dec 10
Love0

Evaluation of Risk of Major Adverse Cardiovascular Events with Biologic Therapy in Patients with Psoriasis (Errata)

By No Comments
Dear Editor, Due to an inadvertent omission by the Sponsor (Janssen Scientific Affairs, LLC, Horsham, PA, United States) of preferred terms (PTs) from the Medical Dictionary for Regulatory Activities (MedDRA)…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • JDD Re:View With Dr. Beer May 14, 2026
  • JDD May 2026 Highlights and Editor Picks May 13, 2026
  • Tune in for the next podcast-style DermEdge episode May 12, 2026
  • Psoriatic Arthritis Awareness Month May 11, 2026
  • GLP-1 Therapies and Dermatology: A Brief Guide May 7, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram